10-Q quarterly report · filed Oct 28, 2026

ORTHOPEDIATRICS CORP (KIDS) Q3 2026 10-Q Quarterly Report

Short answer

ORTHOPEDIATRICS CORP (KIDS) filed its Q3 2026 10-Q quarterly report on Oct 28, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $73M (up 18.6% year over year) with net income of −$6M.

Q3 2026 key financials · XBRL

Revenue
$73M
+18.6% YoY · +3.1% QoQ
Net income
−$6M
+49.6% YoY · +17.2% QoQ
Operating margin
-5.8%
Gross margin
74.3%
EPS (diluted)
−$0.24
+52.0% YoY · +20.0% QoQ

Source: XBRL data from the ORTHOPEDIATRICS CORP (KIDS) Q3 2026 10-Q on SEC EDGAR. USD.

ORTHOPEDIATRICS CORP Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $72.7M, up 19% YoY from $61.2M
  • Gross margin 74% vs 74% YoY; net loss $5.9M vs $11.8M
  • Best segment Trauma and deformity: $52.6M, up 19%; worst Sports medicine/other: unchanged
  • Operating cash flow $2.1M vs $(15.2)M; liquidity $44.9M at September 30
  • Near-term losses possible amid portfolio expansion and consigned-set investments; $20.0M delayed-draw facility undrawn

Risk Factors

  • No material changes to 10-K risk factors filed March 4, 2026

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other ORTHOPEDIATRICS CORP quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.